In yesterday’s Wall Street session, MetLife Inc. (NYSE:MET) shares traded at $51.88, up 0.35% from the previous session.
As of this writing, 19 analysts cover MetLife Inc. (NYSE:MET). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $86.00 and a low of $60.00, we find $74.00. Given the previous closing price of $51.70, this indicates a potential upside of 43.13 percent. MET stock price is now -10.01% away from the 50-day moving average and -22.18% away from the 200-day moving average. The market capitalization of the company currently stands at $40.53B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
There are 4 analysts who have given it a hold rating, whereas 13 have given it a buy rating. Brokers who have rated the stock have averaged $75.80 as their price target over the next twelve months.
With the price target reduced from $80 to $78, Goldman Downgraded its rating from Buy to Neutral for MetLife Inc. (NYSE: MET). On December 09, 2022, Jefferies Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $86 to quote $82, while ‘Raymond James’ rates the stock as ‘Mkt Perform’.
In other news, PAPPAS BILL, EVP, Global Tech. & Ops. sold 2,857 shares of the company’s stock on Mar 02. The stock was sold for $202,733 at an average price of $70.96. Upon completion of the transaction, the EVP, Global Tech. & Ops. now directly owns 48,915 shares in the company, valued at $2.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 27, EVP, Global Tech. & Ops. PAPPAS BILL sold 11,345 shares of the business’s stock. A total of $816,386 was realized by selling the stock at an average price of $71.96. This leaves the insider owning 46,231 shares of the company worth $2.4 million. Insiders disposed of 479,183 shares of company stock worth roughly $24.86 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in MET stock. A new stake in MetLife Inc. shares was purchased by PRANA CAPITAL MANAGEMENT, LP during the first quarter worth $24,679,000. GILLSON CAPITAL LP invested $19,532,000 in shares of MET during the first quarter. In the first quarter, BALYASNY ASSET MANAGEMENT L.P. acquired a new stake in MetLife Inc. valued at approximately $17,854,000. CAPITAL FUND MANAGEMENT S.A. acquired a new stake in MET for approximately $13,575,000. MKP CAPITAL MANAGEMENT, L.L.C. purchased a new stake in MET valued at around $10,117,000 in the second quarter. In total, there are 1,717 active investors with 75.50% ownership of the company’s stock.
Thursday morning saw MetLife Inc. (NYSE: MET) opened at $51.69. During the past 12 months, MetLife Inc. has had a low of $48.95 and a high of $77.36. According to the stock market information, the enterprise value for the company is $60.47B, which is based on a 28.33 price-to-earnings ratio, a 5.92 price-to-earnings-growth ratio, and a beta of 1.07. The fifty day moving average price for MET is $57.34 and a two-hundred day moving average price translates $66.61 for the stock.
The latest earnings results from MetLife Inc. (NYSE: MET) was released for Mar, 2023. According to the Insurance – Life Company, earnings per share came in at $1.52, missing analysts’ expectations of $1.83 by -0.31. This compares to $1.89 EPS in the same period last year. The net profit margin was 2.50% and return on equity was 5.70% for MET. The company reported revenue of $15.39 billion for the quarter, compared to $15.4 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -0.11 percent. For the current quarter, analysts expect MET to generate $17.05B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 06/14/2023. Investors who held shares on 05/09/2023 were paid a $0.52 dividend. On an annualized basis, this represents a $2.08 dividend and a 4.01% percent yield. There was an ex-dividend date of 05/08/2023 for this dividend. In terms of dividend payout ratio, MET is presently at 89.40%.
MetLife Inc.(MET) Company Profile
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.